Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 551.05M | 372.31M | 408.57M | 362.51M | 259.31M |
Gross Profit | 270.62M | 162.55M | 173.46M | 158.01M | 130.20M |
EBITDA | 89.45M | 15.32M | 48.68M | 50.58M | 39.51M |
Net Income | 61.86M | -25.68M | 12.56M | 14.98M | 1.65M |
Balance Sheet | |||||
Total Assets | 452.43M | 369.43M | 395.07M | 401.03M | 361.69M |
Cash, Cash Equivalents and Short-Term Investments | 68.52M | 34.16M | 76.46M | 102.10M | 114.74M |
Total Debt | 67.67M | 48.18M | 51.07M | 46.15M | 54.61M |
Total Liabilities | 206.50M | 174.39M | 155.81M | 150.74M | 124.82M |
Stockholders Equity | 245.93M | 195.03M | 239.26M | 249.67M | 236.13M |
Cash Flow | |||||
Free Cash Flow | 0.00 | -10.86M | -6.54M | 6.37M | 2.83M |
Operating Cash Flow | 79.64M | 21.25M | 46.52M | 42.55M | 26.15M |
Investing Cash Flow | 0.00 | -31.13M | -58.83M | -35.63M | -23.21M |
Financing Cash Flow | 0.00 | -21.05M | -11.73M | -19.43M | 74.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $83.28B | 12.31 | 18.17% | 8.81% | 12.76% | 34.50% | |
70 Outperform | $159.12B | 12.89 | 11.39% | 2.78% | -2.65% | -14.96% | |
67 Neutral | HK$156.00M | 2.52 | 28.06% | 9.38% | 48.01% | ― | |
66 Neutral | HK$24.15B | 27.06 | 25.73% | ― | 168.87% | 150.80% | |
62 Neutral | $16.85B | 11.50 | -7.38% | 2.96% | 1.59% | -23.36% | |
40 Neutral | $1.80B | ― | ― | -4.77% | -15.54% |
Cirtek Holdings Limited has announced its upcoming Annual General Meeting (AGM) scheduled for June 20, 2025, in Hong Kong. The meeting will address several key resolutions, including the adoption of financial statements for the year ending December 31, 2024, re-election of directors, approval of a final dividend, and re-appointment of Ernst & Young as auditors. Additionally, a mandate will be discussed regarding the issuance of additional shares, which could impact the company’s capital structure and shareholder value.
Cirtek Holdings Limited reported a significant turnaround in its financial performance for the year ended December 31, 2024, with a profit attributable to owners of the company amounting to HK$61.9 million, compared to a loss of HK$25.7 million in the previous year. This improvement in profitability, despite a comprehensive loss due to exchange differences, reflects positively on the company’s operational efficiency and market positioning, potentially enhancing stakeholder confidence.
Cirtek Holdings Limited has announced a final ordinary cash dividend of HKD 0.0075 per share for the financial year ending December 31, 2024. The dividend will be paid on July 18, 2025, following shareholder approval on June 20, 2025, with the ex-dividend date set for June 24, 2025. This announcement reflects the company’s commitment to returning value to its shareholders and may influence investor sentiment and market perception of the company’s financial health.
Cirtek Holdings Limited has announced the postponement of its board meeting originally scheduled for March 28, 2025, to March 31, 2025. This delay is due to the need for additional time to prepare and finalize the company’s audited annual results for the year ending December 31, 2024. The meeting will address the approval of these results and the consideration of a final dividend, impacting the company’s financial reporting timeline and potentially influencing stakeholder expectations.
Cirtek Holdings Limited announced a positive profit alert, expecting a profit before tax of not less than HK$65.0 million for the year ended December 31, 2024, marking a significant turnaround from a loss of approximately HK$19.7 million in the previous year. This improvement is attributed to increased sales orders and enhanced production efficiency, as well as effective cost management through global resource allocation.
Cirtek Holdings Limited has announced a board meeting scheduled for March 28, 2025, to review and approve the audited annual results for the year ending December 31, 2024. The meeting will also consider the recommendation of a final dividend and address other business matters, potentially impacting the company’s financial strategy and stakeholder interests.